Ilham M Alshiraihi

4PUBLICATIONS
3CO-AUTHORS
Regenerative medicine (incl. stem cells)Nanotoxicology, health and safetyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
RETRACTED: Edwards et al. The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo. Vet. Sci. 2020, 7, 100.

|Feb 04, 2021
Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic.

Ilham M Alshiraihi, Gerald L Klein, Mark A Brown

|Dec 18, 2020
In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells.

Ilham M Alshiraihi, Dillon K Jarrell, Zeyad Arhouma

|Jul 30, 2020
RETRACTED: The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo.

Melissa A Edwards, Mark A Brown, Ilham Alshiraihi

Pageof 1

Frequent Collaborators

2 joint publications

Melissa A Edwards

1 joint publications

Haley O Tucker

1 joint publications

Takamitsu A Kato